Monday, November 17, 2014

Testosterone cypionate 250mg/ml - $250/500ml

Product name: Testosterone cypionate
Synonyms: cyponax;TESTOSTERONE CYCLOPENTANE PROPIONATE;TESTOSTERONE CYCLOPENTYLPROPIONATE
CAS No.: 58-20-8
M.F.: C27H40O3
M.W.: 412.6
Assays: 99.20%
Packing: 1kg/foil bag
Reference Standard: USP28
Appearance: White Or White-off Crystalline Powder

Testosterone cypionate usage:Testosterone Cypionate is the most popular testosterone in USA.Testosterone Cypionate has aromatase action  and the water retain is one of its problems. Testosterone Cypionate is also toxic for the liver and it will decrease the regeneration of endogenous testosterone. In most cases the Testosterone Cypionate gives a considerable increase of strenght and weight but loses after stopping the treatment are considerable .

Testosterone cypionate dosage:Average Dose: Men 250-1000 mg/week

Testosterone cypionate half life: 15-16 days

Testosterone cypionate side effects:
Acne: Yes
Water Retention: Yes, high
High Blood Pressure: Yes
Liver Toxic: Low, except in mega dosages
Aromatization: Yes, high
DHT Conversion: Yes, high
Decrease HPTA function: Yes, severe

Testosterone cypionate Recipes:
250mg/ml@40ml
10 grams Testosterone cypionate
2ml Benzyl Alcohol = 5% BA
30.5 ml sesame oil

Testosterone cypionate cycle:
Week Test C Equipoise Primobolan Clomid Hcg
1 500mg/week 600mg/week 600mg/week 500ui/week
2 500mg/week 600mg/week 600mg/week 500ui/week
3 500mg/week 600mg/week 600mg/week 500ui/week
4 500mg/week 600mg/week 600mg/week 500ui/week
5 500mg/week 600mg/week 600mg/week 500ui/week
6 500mg/week 600mg/week 600mg/week 500ui/week
7 500mg/week 600mg/week 600mg/week 500ui/week
8 500mg/week 600mg/week 600mg/week 500ui/week
9 500mg/week 600mg/week 600mg/week 500ui/week
10 500mg/week 600mg/week 600mg/week 500ui/week
11 500mg/week 600mg/week 600mg/week 500ui/week
12 500mg/week 600mg/week 600mg/week 500ui/week
13 500mg/week 500ui/week
14 500mg/week 500ui/week
15 500mg/week 500ui/week
16 500mg/week 500ui/week
17
18 50mg/day
19 50mg/day
20 50mg/day





No comments:

Post a Comment